The FDA rejected a drug that is meant to boost a woman's libido.
Sprout Pharmaceuticals says it's at an impasse with the agency over the company's pink pill, Flibanserin, leaving the 15-year search for a 'female Viagra' in limbo. Find out more by watching the video below. (Video may not display on some mobile devices)
What are your thoughts CLICK HERE to leave us a "Your2Cents” comment.
© Copyright 2014, A Granite Broadcasting Station. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.